wire - news in brief
Earth Sciences - Nov 20
Health - Nov 19
Killer cells of the immune system detect and kill infected cells or cancer cells. Researchers at the Institute of Pathology at the University of Bern have now discovered that the mechanism by which certain immune cells kill their target cells can also be used to control the killer cells themselves.
Transport - Nov 19
ETH researchers have shown that we can use the structure of urban road networks to predict their traffic capacity.
Category
Results 1 - 50 of 382.
This year Renana Gershoni-Poranne was awarded a Branco Weiss Fellowship. The ETH chemist will use the research grant to design innovative compounds that can be used in future generations of electronic devices.
Empa scientist Mark Schubert and his team would like to use the many opportunities offered by machine learning for wood technology applications. Together with Swiss Wood Solutions, Schubert will present his latest project at the Swiss Innovation Forum on 21 November in Basel. Wood is a natural material that is lightweight and sustainable, with excellent physical properties, which make it an excellent choice for constructing a wide range of products with high quality requirements - for example for musical instruments and sports equipment.
EPFL hosts a new SBB innovation unit
Swiss Federal Railways (SBB) opened a new innovation unit today at EPFL's Innovation Park, further deepening its ties with the School.
Swiss Federal Railways (SBB) opened a new innovation unit today at EPFL's Innovation Park, further deepening its ties with the School.
The first-ever image of a black hole was unveiled to the public this past April. It was produced by a team of 200 scientists as part of the Event Horizon Telescope Project.
Novartis PARAGON-HF analyses suggest Entresto benefit beyond HFrEF
Patients & Caregivers Healthcare Professionals Society & ESG Entresto (sacubitril/valsartan) demonstrated greatest benefit in HFpEF patients with ejection fractions adjacent to HFrEF, compare
Patients & Caregivers Healthcare Professionals Society & ESG Entresto (sacubitril/valsartan) demonstrated greatest benefit in HFpEF patients with ejection fractions adjacent to HFrEF, compare
New Novartis medicine Adakveo (crizanlizumab) approved by FDA to reduce frequency of pain crises in individuals living with sickle cell disease
Patients & Caregivers Healthcare Professionals Society & ESG Sickle cell pain crises are unpredictable, severe events associated with life-threatening complications 1 Adakveo reduced the an
Patients & Caregivers Healthcare Professionals Society & ESG Sickle cell pain crises are unpredictable, severe events associated with life-threatening complications 1 Adakveo reduced the an
Novartis receives positive CHMP opinion for Mayzent (siponimod) for the treatment of adult patients with active secondary progressive multiple sclerosis (SPMS)
Patients & Caregivers Healthcare Professionals Society & ESG If approved, Mayzent (siponimod) will be the first and only oral treatment specifically indicated for patients with active seconda
Patients & Caregivers Healthcare Professionals Society & ESG If approved, Mayzent (siponimod) will be the first and only oral treatment specifically indicated for patients with active seconda
EPFL researchers have developed a geothermal system for recovering the heat captured in basements, subway tunnels and underground parking garages.
This year's Johanna Dürmüller-Bol DBMR Research Award of the Department for BioMedical Research (DBMR) of the University of Bern goes to Maria-Nieves Sanz.
The next generation of ultra high-performance fiber-reinforced concrete (UHPFRC) has just been created at EPFL. The new material will be used to strengthen bridges and other structures - both new and old. What's more, the process of manufacturing this material releases 60-70% less CO2 than the previous generation of fiber-reinforced concrete.
New Novartis PREVENT data show Cosentyx delivers early relief in axial spondyloarthritis
Patients & Caregivers Healthcare Professionals Society & ESG 42.2% of patients with non-radiographic axial spondyloarthritis (nr-axSpA) treated with Cosentyx had improved ASAS40 scores
Patients & Caregivers Healthcare Professionals Society & ESG 42.2% of patients with non-radiographic axial spondyloarthritis (nr-axSpA) treated with Cosentyx had improved ASAS40 scores
Sandoz presents real-world data showing effectiveness of Erelzi (etanercept-szzs) in rheumatic disease treatment
Patients & Caregivers Healthcare Professionals Society & ESG Interim results from COMPACT, a multi-country, real-world study of Erelzi for approved rheumatic diseases presented at 2019 ACR/AR
Patients & Caregivers Healthcare Professionals Society & ESG Interim results from COMPACT, a multi-country, real-world study of Erelzi for approved rheumatic diseases presented at 2019 ACR/AR
A chat with the expert: Luca Gambardella
The series of talks "Quattro chiacchiere con l'esperto", organised by USI Ideatorio Cadro, continues with Luca Gambardella, Director of Dalle Molle Institute for Artificial Intelligence USI-SUPSI. An informal chat with the expert about the human brain vs artificial intelligence. Computer scientist Luca Gambardella is the Director of Dalle Molle Institute for Artificial Intelligence (USI-SUPSI), for which he began working in 1988.
The series of talks "Quattro chiacchiere con l'esperto", organised by USI Ideatorio Cadro, continues with Luca Gambardella, Director of Dalle Molle Institute for Artificial Intelligence USI-SUPSI. An informal chat with the expert about the human brain vs artificial intelligence. Computer scientist Luca Gambardella is the Director of Dalle Molle Institute for Artificial Intelligence (USI-SUPSI), for which he began working in 1988.
Roche’s Gazyva (obinutuzumab), in combination with standard of care, more than doubles the percentage of lupus nephritis patients achieving complete renal response, compared to standard of care alone
Roche today announced data from the phase II NOBILITY study, investigating the safety and efficacy of Gazyva (obinutuzumab) for adults with proliferative lupus nephritis.
Roche today announced data from the phase II NOBILITY study, investigating the safety and efficacy of Gazyva (obinutuzumab) for adults with proliferative lupus nephritis.
Roche’s risdiplam meets primary endpoint in pivotal SUNFISH trial in people with type 2 or 3 spinal muscular atrophy
Roche today announced positive data from the pivotal Part 2 of SUNFISH, a study evaluating risdiplam in people aged 2-25 years with Type 2 or 3 spinal muscular atrophy (SMA).
Roche today announced positive data from the pivotal Part 2 of SUNFISH, a study evaluating risdiplam in people aged 2-25 years with Type 2 or 3 spinal muscular atrophy (SMA).
EPFL aims to build trust in fintechs
A new research program will combine the specialist knowledge of the Swiss Finance Institute @ EPFL with insights from the School's data scientists and digital trust experts.
A new research program will combine the specialist knowledge of the Swiss Finance Institute @ EPFL with insights from the School's data scientists and digital trust experts.
ETH researchers are planning to partner with clinics, foundations, public authorities and other institutions through a broad-based initiative aimed at improving the quality of life and participation of people with physical disabilities.
Dominik Hangartner, a political scientist at ETH Zurich, has received one of Switzerland's most prestigious science awards. The National Latsis Prize has recognised the quality of Hangartner's research on migration and its importance for public policy. We sat down with Hangartner to find out what drives him and what he finds so exciting about turning research into concrete policies.
EPFL's student bioengineering team has won the Grand Prize of the 2019 International Genetically Engineered Machine (iGEM) competition, as well as the Best Environment Project.
Hackers are increasingly exploiting weaknesses in IT system hardware rather than software. To close this gap, we are introducing a new open source project based on Google's Titan security technology and the "Ibex" open source processor from ETH. Luca Benini, Professor at the Institute for Integrated Systems, explains how.
Sustainable investments are on the rise, but does impact follow? The new UZH report on sustainable investing capabilities urges private banks to gear up their services to meet investor demands ' and environmental targets.
Data innovation strategy: FSO pilot projects point to productivity gains
Official statistics can benefit from new analysis methods arising from its data innovation strategy. The automation of certain tasks, especially data preparation, seems to be particularly promising. Although the first results from the FSO's pilot projects are encouraging, according to an initial assessment published on the "experimental statistics" microsite, they still need fine-tuning before they can be fully implemented in ongoing production.
Official statistics can benefit from new analysis methods arising from its data innovation strategy. The automation of certain tasks, especially data preparation, seems to be particularly promising. Although the first results from the FSO's pilot projects are encouraging, according to an initial assessment published on the "experimental statistics" microsite, they still need fine-tuning before they can be fully implemented in ongoing production.
EPFL-based startup Droople has developed a smart flow meter that can measure buildings' water consumption and identify potential savings in energy.
Novartis Cosentyx shows encouraging results versus Humira * from first-of-its-kind head-to-head trial in psoriatic arthritis
Cosentyx narrowly missed statistical significance for superiority in ACR 20, the primary endpoint of the EXCEED trial, while showing numerically higher results versus Humira * Statistically signifi
Cosentyx narrowly missed statistical significance for superiority in ACR 20, the primary endpoint of the EXCEED trial, while showing numerically higher results versus Humira * Statistically signifi
News By: Michèle Marti and Felix Würsten Twenty years ago, Switzerland ratified the Comprehensive Nuclear-Test-Ban Treaty.
Energy geostructures provide a constant source of renewable heating and cooling in buildings and infrastructures and perform very well.
The Dark Energy Spectroscopic Instrument (DESI), is a US-led project that will measure the accelerated expansion of the Universe in order to reveal the nature of dark energy. The DESI project, which has received significant contributions from EPFL's astrophysicists, is entering its final testing phase, gearing up to charter the skies.
"Science Wire" gives access to latest science news from universities, research centers and R&D companies.Add this page to your bookmarks
